STOCK COMMENTS / EPS CHANGESARIAD Pharma ( ARIA) target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating. Anheuser-Busch InBev ( BUD) added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target. Celanese ( CE) numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance. Generac ( GNRC) estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating. International Paper ( IP) numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp. Kronos Worldwide ( KRO) numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating. Pentair ( PNR) numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating. Travelers ( TRV) cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.
STRATEGY CALLS / MARKET CALLSMedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.